Product Code: ETC089523 | Publication Date: Jun 2021 | Updated Date: Apr 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The antiparasitic drugs market in Bahrain is expanding as the country continues to address parasitic infections, particularly those related to travel and imported cases. Antiparasitic drugs are essential in treating diseases caused by parasites, including malaria, helminth infections, and other parasitic diseases. With increasing awareness of public health and access to healthcare services, the demand for antiparasitic medications is rising in Bahrain. The market is also influenced by advancements in drug formulations and the development of more effective treatments.
The antiparasitic drugs market in Bahrain is growing as a result of the increasing incidence of parasitic infections and the rising awareness of their prevention and treatment. Parasitic diseases, such as malaria and intestinal infections, are a significant public health concern, and the demand for effective antiparasitic medications is rising in response. Government efforts to improve healthcare services and expand access to essential drugs are driving the market for antiparasitic treatments. Additionally, the growing focus on animal healthcare in Bahrain, particularly in livestock and pets, is contributing to the demand for veterinary antiparasitic drugs.
The antiparasitic drugs market in Bahrain is essential for the treatment of parasitic infections in humans and animals. However, the market faces challenges due to the growing problem of drug resistance among parasites, which reduces the efficacy of traditional antiparasitic treatments. The development of new drugs requires significant research and development investment, which may deter smaller pharmaceutical companies from entering the market. Additionally, competition from herbal and alternative treatments for parasitic infections, which are gaining popularity, impacts the demand for conventional antiparasitic drugs. Regulatory hurdles and the need for clinical trials further complicate the market.
The antiparasitic drugs market in Bahrain is driven by the demand for treatments in both human and veterinary medicine. Investment opportunities exist in supplying antiparasitic drugs to hospitals, clinics, and veterinary practices. Investors can target partnerships with pharmaceutical distributors and healthcare providers to meet the growing need for effective treatments against parasitic infections in both humans and animals.
The antiparasitic drugs market in Bahrain is influenced by demand from the healthcare and veterinary sectors. Government policies promoting public health and access to essential medicines have supported the growth of the market for antiparasitic drugs. Import regulations ensure that these drugs meet international safety and efficacy standards, while local initiatives aimed at improving healthcare and animal welfare have further driven the demand for antiparasitic medications in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Antiparasitics Drugs Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Antiparasitics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Bahrain Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Bahrain Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Bahrain Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Bahrain Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Bahrain Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bahrain Antiparasitics Drugs Market Trends |
6 Bahrain Antiparasitics Drugs Market, By Types |
6.1 Bahrain Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2018 - 2027F |
6.1.3 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Oral, 2018 - 2027F |
6.1.4 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2018 - 2027F |
6.1.5 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Topical, 2018 - 2027F |
6.2 Bahrain Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2018 - 2027F |
6.2.3 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2018 - 2027F |
6.2.4 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 Bahrain Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2027F |
6.3.3 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2018 - 2027F |
6.3.4 Bahrain Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2018 - 2027F |
7 Bahrain Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Bahrain Antiparasitics Drugs Market Export to Major Countries |
7.2 Bahrain Antiparasitics Drugs Market Imports from Major Countries |
8 Bahrain Antiparasitics Drugs Market Key Performance Indicators |
9 Bahrain Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Bahrain Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Bahrain Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Bahrain Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Bahrain Antiparasitics Drugs Market - Competitive Landscape |
10.1 Bahrain Antiparasitics Drugs Market Revenue Share, By Companies, 2021 |
10.2 Bahrain Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |